In 2020, Zhang et al. and co-workers demonstrated that the interaction between DSCAM-AS1 and YBX1 promotes cancer progression through the activation of FOXA1 transcription network in lung adenocarcinoma, breast and prostate (46). This evidence concerns the gene YBX1 and cancer.